Sodium phenylbutyrate is known to stabilize the mutant cystic fibrosis transmembrane conductance regulator (CFTR) protein in the ER and circumvent the phenotype associated with destabilizing mutations in cystic fibrosis (Dunmore et al., 2020). Here, CFTR is linked to cystic fibrosis.